Microarray analysis of gene expression profile by treatment of Cinnamomi Ramulus in lipopolysaccharide-stimulated BV-2 cells

Gene

Volumn 443, Issue 1-2, 2009, Pages 83-90

  Hwang, Se Hee ^a   Choi, Yeong Gon ^a,b   Jeong, Mi Young ^a,b   Hong, Yeon Mi ^a,b   Lee, Je Hyun ^c   Lim, Sabina ^a,b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Dongguk University   (South Korea)

Author keywords

BV 2 cell; Cinnamomi Ramulus; Lipopolysaccharide; Microarray

Indexed keywords

B7 ANTIGEN; CHEMOKINE; CINNAMOMUM CASSIA EXTRACT; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IFI203 PROTEIN; IFIT1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LILRB3 PROTEIN; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; RAB PROTEIN; RAB2B PROTEIN; RANTES; RSAD2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VPREB1 PROTEIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRANCHLET; CINNAMOMUM; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DOWN REGULATION; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CINNAMOMUM; GENE EXPRESSION PROFILING; LIPOPOLYSACCHARIDES; MICE; MICROGLIA;

CINNAMOMI;

EID: 67449092717     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.04.024     Document Type: Article

References (74)

1. Abraham J., Jang S., Godbout J.P., Chen J., Kelley K.W., Dantzer R., and Johnson R.W. Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiol. Aging 29 (2006) 614-621
2. Adams V., Nehrhoff B., Späte U., Linke A., Schulze P.C., Baur A., Gielen S., Hambrecht R., and Schuler G. Induction of iNOS expression in skeletal muscle by IL-1 and NF-κB activation: an in vitro and in vivo study. Cardiovasc. Res. 54 (2002) 95-104
3. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., and Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153 (1998) 801-813
4. Aloisi F. Immune function of microglia. Glia 36 (2001) 165-179
5. Baeuerle P.A., and Baltimore D. NF-kappaB: ten years after. Cell 87 (1996) 13-20
6. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insight. Annu. Rev. Immunol. 14 (1996) 649-683
7. Blasi E., Barluzzi R., Bocchini V., Mazzolla R., and Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27 (1990) 229-237
8. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31 (1999) 577-596
9. Busse R., and Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann. Med. 27 (1995) 331-340
10. Bussemaker H.J., Ward L.D., and Noorsma A. Dissecting complex transcriptional responses using pathway level scores based on prior information. BMC Bioinformatics, Review 8 Suppl. 6 (2007) s6
11. Chao C.C., Hu S., Ehrlich L., and Peterson P.K. Interleukin-1 and tumor necrosis factor-α synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-Daspartate receptors. Brain Behav. Immun. 9 (1995) 355-365
12. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., and Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149 (1992) 2736-2741
13. Chew L.J., Takanohashi A., and Bell M. Microglia and inflammation: impact on developmental brain injuries. Ment. Retard. and Dev. Disabil. Res. Rev. 12 (2006) 105-112
14. Cho Y.H., Kim K.S., and Lee S.D. The effect of Ramulus Cinnamomum aqua-acupuncture on the cellular immune responses to LPS induced arthritis in mice. J. Korean Acupuncture and Moxibustion Soc. 18 (2001) 100-112
15. Christensen J.E., de Lemos C., Moos T., Christensen J.P., and Thomsen A.R. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J. Immunol. 176 (2006) 4235-4243
16. Clark W.M., Rinker L.G., Lessov N.S., Hazel K., and Eckenstein F. Time course of IL-6 expression in experimental CNS ischemia. Neurol. Res. 21 (1999) 287-292
17. Dufour J.H., Dziejman M., Liu M.T., Leung J.H., Lane T.E., and Luster A.D. IFN-γ-inducible protein 10 (IP-10, CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168 (2002) 3195-3204
18. Eugenin E.A., and Berman J.W. Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 29 (2003) 351-361
19. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., Sims J.E., Bird T.A., and O'Neill L.A. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413 (2001) 78-83
20. Förstermann U., and Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 351-364
21. Gadient R.A., and Otten U.H. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52 (1997) 379-390
22. Genin P., Algarte M., Roof P., Lin R., and Hiscott J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappaB and IFN-regulatory factor transcription factors. J. Immunol. 164 (2000) 5352-5361
23. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell 111 (2002) 927-930
24. Gruol D.L., and Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15 (1997) 307-339
25. Guo H., Jin Y.X., Ishikawa M., Huang Y.M., van der Meide P.H., Link H., and Xiao B.G. Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, pro-inflammatory and immunoregulatory cytokines. Scand. J. Immunol. 48 (1998) 502-508
26. Guo J.Y., Huo H.R., Zhao B.S., Liu H.B., Li L.F., Ma Y.Y., Guo S.Y., and Jiang T.L. Cinnamaldehyde reduces IL-1β-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells. Eur. J. Pharmacol 537 (2006) 174-180
27. Henkel T., Machleidt T., Alkalay I., Krönke M., Ben-Neriah Y., and Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365 (1993) 182-185
28. Hobbs A.J., Higgs A., and Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 191-220
29. Hoozemans J.J., Veerhuis R., Janssen I., van Elk E.J., Rozemuller A.J., and Eikelenboom P. The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease. Brain Res. 951 (2002) 218-226
30. Horng T., Barton G.M., and Medzhitov R. TIRAP; an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2 (2001) 835-841
31. Hou R.S., Chen H.L., Tzen J.T., and Jeng K.C. Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport 14 (2003) 1815-1819
32. Hu S., Chao C.C., Ehrlich L.C., Sheng W.S., Sutton R.L., Rockswold G.L., and Peterson P.K. Inhibition of microglial cell RANTES production by IL-10 and TGF-beta. J. Leukocyte Biol. 65 (1999) 815-821
33. Ishii K.J., Coban C., and Akira S. Manifold mechanisms of toll-like receptor-ligand recognition. J. Clin. Immunol. 25 (2005) 511-521
34. Jang S.B., Won J., Kim H., Kim J., Lee K.H., Han H., Rha H.K., and Choi C.R. TAK1 mediates lipopolysaccharide-induced RANTES promoter activation in BV-2 microglial cells. Mol. Cells 14 (2002) 35-42
35. Jeong M.Y., Lee J.S., Lee J.D., Kim N.J., Kim J.W., and Lim S. A combined extract of Cinnamomi Ramulus, Anemarrhenae Rhizoma and Alpiniae Officinari Rhizoma suppresses production of nitric oxide by inhibiting NF-kappaB activation in RAW 264.7 cells. Phytother. Res. 22 6 (2008) 772-777
36. Kameyoshi Y., Dörschner A., Mallet A.I., Christophers E., and Schröder J.M. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176 (1992) 587-592
37. Kang G., Kong P.J., Yuh Y.J., Lim S.Y., Yim S.V., Chun W., and Kim S.S. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor B bindings in BV2 microglial cells. J. Pharmacol. Sci. 94 (2004) 325-328
38. Karin M., and Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signaling. Semin. Immunol. 12 (2000) 85-98
39. Kim D.H., Kim C.H., Kim M.S., Kim J.Y., Jung K.J., Chung J.H., An W.G., Lee J.W., Yu B.P., and Chung H.Y. Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde. Biogerontology 8 (2007) 545-554
40. Kim J.Y., Jung K.S., and Jeong H.G. Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages. FEBS Lett. 569 (2004) 321-326
41. Kim W.K., Jang P.G., Woo M.S., Han I.O., Piao H.Z., Lee K., Lee H., Joh T.H., and Kim H.S. A new anti-inflammatory agent KL-1037 represses proinflammatory cytokine and inducible nitric oxide synthase (iNOS) gene expression in activated microglia. Neuropharmacology 47 (2004) 243-252
42. Kremlev S.G., Roberts R.L., and Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J. Neuroimmunol. 149 (2004) 1-9
43. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
44. Kuna P., Reddigari S.R., Schall T.J., Rucinski D., Viksman M.Y., and Kaplan A.P. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophiles. J. Immunol. 149 (1992) 636-642
45. Lawrence T., Gilroy D.W., and Colville-Nash P.R. Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7 (2001) 1291-1297
46. Lee H.S., Kim B.S., and Kim M.K. Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase. J. Agric. Food Chem. 50 (2002) 7700-7703
47. Liang Y.C., Huang Y.T., Tsai S.H., Lin-Shiau S.Y., Chen C.F., and Lin J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20 (1999) 1945-1952
48. Liao B.C., Hsieh C.W., Liu Y.C., Tzeng T.T., Sun Y.W., and Wung B.S. Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2. Toxicol. Appl. Pharmacol. 229 (2008) 161-171
49. Lu D.Y., Tang C.H., Liou H.C., Teng C.M., Jeng K.C., Kuo S.C., Lee F.Y., and Fu W.M. YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-κB in microglia. British J. Pharmacol. 151 (2007) 396-405
50. Lucas S.M., Rothwell N.J., and Gibson R.M. The role of inflammation in CNS injury and disease. British J. Pharmacol. 147 (2006) 240-282
51. Lyu S.A., Lee S.Y., Lee S.J., Son S.W., Kim M.O., Kim G.Y., Kim Y.H., Yoon H.J., Kim H., Park D.I., and Ko W.S. Seungma-galgeun-tang attenuates proinflammatory activities through the inhibition of NF-κB signal pathway in the BV-2 microglial cells. J. Ethnopharmacol. 107 (2006) 59-66
52. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
53. McGuire S.O., Ling Z.D., Lipton J.W., Sortwell C.E., Collier T.J., and Carvey P.M. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Experimental Neurology 169 (2001) 219-230
54. Moriuchi H., Moriuchi M., and Fauci A.S. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158 (1997) 3483-3491
55. Nagai A., Mishima S., Ishida Y., Ishikura H., and Harada T. Immortalized human microglial cell line: phenotypic expression. J. Neurosci. Res. 81 (2005) 342-348
56. Nakajima K., and Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4 (2004) 65-84
57. Oh J.W., Schwiebert L.M., and Benveniste E.N. Cytokine regulation of CC and CXC chemokine expression by human astrocytes. J. Neurovirol. 5 (1999) 82-94
58. Park H.J., Lee J.S., Lee J.D., Kim N.J., Pyo J.H., Kang J.M., Choe H., Kim S.Y., Shim B.S., Lee J.H., and Lim S. The anti-inflammatory effect of Cinnamomi Ramulus. J. Korean Oriental Med. 26 (2005) 140-151
59. Piao H.Z., Jin S.A., Chun H.S., Lee J.C., and Kim W.K. Neuroprotective effect of wogonin: potential roles of inflammatory cytokines. Arch. Pharm. Res. 27 (2004) 930-936
60. Pyo J.H. Effects of Cinnamomi Ramulus' major component 'Trans-Cinnamaldehyde' on 6-Hydroxydopamine-Induced Dopaminergic Dysfunction in Mice (2008), Kyung Hee University, School of Eastern Medicine
61. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., Koch A.E., Moser B., and Mackay C.R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reaction. J. Clin. Invest. 101 (1998) 746-754
62. Raso G.M., Meli R., Di Carlo G., Pacilio M., and Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci. 68 (2001) 921-931
63. Reddy A.M., Seo J.H., Ryu S.Y., Kim Y.S., Kim Y.S., Min K.R., and Kim Y. Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-kappaB inhibitors from Cinnamomum cassia. Planta Med. 70 (2004) 823-827
64. Rothwell N.J., and Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23 (2000) 618-625
65. Sedgwick J.D., Riminton D.S., Cyster J.G., and Korner H. Tumor necrosis factor: a master-regulator leukocyte movement. Immunology Today 21 (2000) 110-113
66. Shen Q., Zhang R., and Bhat N.R. MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells. Brain Res. 1086 (2006) 9-16
67. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., and Mariani C.L. Role of microglia in the central nervous system's immune response. Neurol. Res. 27 (2005) 685-691
68. Sun D., Hu X., Liu X., Whitaker J.N., and Walker W.S. Expression of chemokine genes in rat glia cells: the effect of myelin basic protein-reactive encephalitogenic T cells. J. Neurosci. Res. 48 (1997) 192-200
69. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., and Fukuchi K. Role of toll-like receptor signaling in Aβ uptake and clearance. Brain 129 (2006) 3006-3019
70. Taub D.D., Sayers T.J., Carter C.R., and Ortaldo J.R. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155 (1995) 3877-3888
71. Taupin V., Renno T., Bourbonniere L., Peterson A.C., Rodriguez M., and Owens T. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur. J. Immunol. 27 (1997) 905-913
72. Thornton S., Sowders D., Aronow B., Witte D.P., Brunner H.I., Giannini E.H., and Hirsch R. DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin. Immunol. 105 (2002) 155-168
73. Ward S.G., Bacon K., and Westwick J. Chemokines and T-lymphocytes: more than just an attraction. Immunity 9 (1998) 1-11
74. Xie Q.W., Whisnant R., and Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J. Exp. Med. 177 (1993) 1779-1784